Market Cap

Agenus Inc. Market Capitalization:

$109.8 Million

USD as of Jan. 1, 2026

business Agenus Inc. Company Profile

Agenus Inc. Main Stock Listing

NASDAQ: AGEN

Market Capitalization History of Agenus Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Agenus Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $109.8 M 30.31%
Jan. 1, 2025 $84.3 M -71.75%
Jan. 1, 2024 $298.4 M -66.81%
Jan. 1, 2023 $899.2 M 6.88%
Jan. 1, 2022 $841.3 M -25.00%
Jan. 1, 2021 $1.12 B -1.60%
Jan. 1, 2020 $1.14 B 10.98%
Jan. 1, 2019 $1.03 B -6.65%
Jan. 1, 2018 $1.10 B -9.75%
Jan. 1, 2017 $1.22 B 26.98%
Jan. 1, 2016 $960.2 M -37.38%
Jan. 1, 2015 $1.53 B 62.78%
Jan. 1, 2014 $941.9 M -32.09%
Jan. 1, 2013 $1.39 B 63.67%
Jan. 1, 2012 $847.4 M -49.64%
Jan. 1, 2011 $1.68 B 22.67%
Jan. 1, 2010 $1.37 B 97.37%
Jan. 1, 2009 $695.0 M -82.49%
Jan. 1, 2008 $3.97 B 11.86%
Jan. 1, 2007 $3.55 B -61.58%
Jan. 1, 2006 $9.24 B -39.16%
Jan. 1, 2005 $15.18 B -23.57%
Jan. 1, 2004 $19.86 B 13.84%
Jan. 1, 2003 $17.45 B -31.61%
Jan. 1, 2002 $25.51 B -11.43%
Jan. 1, 2001 $28.80 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Agenus Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Agenus Inc. has the following listings and related stock indices.


Stock: NASDAQ: AGEN

Stock: FSX: AJ81

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.